血清CA19-9异常增高的胆总管结石7例诊治体会  

Experience of Diagnosis and Treatment of 7 Cases of Common Bile Duct Stones with Abnormal Increase of Serum CA19-9

作　　者：刘立民[1] 张宗明[1] 刘卓[1] 张翀[1] 于宏伟 刘子旭[1] 朱明文[1] 宋蒙蒙[1] 赵月 

机构地区：[1]首都医科大学北京电力医院普外科,北京

出　　处：《外科（汉斯）》2017年第1期8-12,共5页Hans Journal of Surgery

摘　　要：血清CA19-9是一种常见的肿瘤标志物,其升高多见于各种消化系统恶性肿瘤患者,尤其是胆管癌、胰腺癌,对于鉴别胆道良、恶性疾病具有重要参考价值。胆道良性疾病患者,血清CA19-9异常升高者少见。本文结合7例血清CA19-9异常升高的胆总管结石患者的诊治体会,深入探讨胆总管结石患者血清CA19-9异常升高的病因、诊断和治疗,以期有效提高血清CA19-9异常升高的胆道良性疾病患者的诊治效果、避免胆道恶性肿瘤的误诊和误治。Serum CA19-9 is one of the most common tumor markers whose elevation is common in patients with various malignant tumors of digestive system, especially bile duct carcinoma, pancreatic cancer, which has important reference value in the differential diagnosis of benign and malignant biliary diseases. Patients with benign biliary tract disease, abnormal elevated serum CA19-9 are rare. Based on our experience of abnormal increase of serum CA19-9 in 7 patients with choledocholithiasis, this paper will further investigate the etiology, diagnosis and treatment of bile duct stones in patients with abnormal serum CA19-9 increased, so as to effectively improve the diagnosis and treatment effect of the biliary tract benign disease patients with abnormal elevated serum CA19-9, and to avoid misdiagnosis and mistreatment of biliary tract malignant tumor.

关 键 词：胆总管结石 急性胆管炎 血清CA19-9 

分 类 号：R73[医药卫生—肿瘤]